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Abstract: There is increasingly broad global recognition of the need to better understand 
determinants of vaccine acceptance. Fifteen social science, communication, health, and 
medical professionals (the ―Motors of Trust in Vaccination‖ (MOTIV) think tank) explored 
factors relating to vaccination decision-making as a step to building a multidisciplinary 
research agenda. One hundred and forty seven factors impacting decisions made by consumers, 
professionals, and policy makers on vaccine acceptance, delay, or refusal were identified 
and grouped into three major categories: cognition and decision-making; groups and social 
norms; and communication and engagement. These factors should help frame a 
multidisciplinary research agenda to build an evidence base on the determinants of vaccine 
acceptance to inform the development of interventions and vaccination policies.  
Keywords: vaccination; policy; communication; attitudes  
 
  
OPEN ACCESS 
Vaccines 2013, 1 294 
 
 
1. Introduction  
Immunization has saved millions of lives worldwide since the introduction of the first vaccine more 
than 200 years ago. However, the sustained success of immunization programs, a cornerstone of public 
health, is challenged by increasing vaccine questioning, hesitancy, and refusals. These occur for a 
range of reasons varying from religious and philosophical to concerns about vaccine safety and 
schedules, or questions about the relevance of some vaccines [1,2]. Moreover, for each vaccine and its 
target disease(s) there is a unique set of interested ―publics‖ with different positive and negative 
perceptions and attitudes to vaccination. High profile vaccine scares have brought significant disruption 
or cessation to entire vaccine programs. For example, despite Andrew Wakefield‘s 1998 article in The 
Lancet [3] being refuted, retracted, and declared fraudulent [4], uptake of measles, mumps and rubella 
(MMR) vaccination dipped in the UK from 91% in 1998 to 80% by 2004 [5]. There have since been 
several outbreaks of measles and, 14 years after the local transmission of measles was halted in the 
UK, the disease was once again reported to be endemic in 2008 [6], and the beginning of 2013 saw the 
highest rates of measles in two decades. In both 2010 and 2011, there were over 30,000 cases annually 
of measles in the European region [7]. In another instance, in 2003 five states in Northern Nigeria 
ordered the boycott of the oral polio vaccine (OPV), alleging that the vaccines were contaminated with 
anti-fertility substances in a plot by Western governments to reduce the Muslim population [8]. As a 
result of the boycott, polio reappeared in more than 15 formerly polio-free African countries (and as 
far afield as Indonesia) [9], and challenges to eradication persist [10]. A more recent example of 
widespread vaccine refusals was during the 2009–2010 response to the (A)H1N1 pandemic threats, 
during which populations, including health professionals, around the world had dismally low acceptance of 
the Influenza A (H1N1) vaccine for a complex mix of reasons from perception of low-to-no disease 
risk, suspicions around the motives of government and the pharmaceutical industry, and historic 
memories of reports of an earlier swine flu vaccine causing Guillain–Barré syndrome (GBS). These 
examples highlight the complex social, historical, political, and power dimensions that influence 
vaccination uptake [1]. 
These experiences and the research on drivers of vaccination behavior have shown that vaccination 
decision-making is driven by different factors according to individual or group experiences and 
contexts, beliefs, and knowledge. Dependent on the viewpoint of the public/s, healthcare professional 
or government/healthcare system, the spectrum of attitudes toward vaccines ranges from considering 
them to be life-saving, to viewing them as a danger to health. Research also demonstrates that facts 
only go so far in determining decision-making; cognitive heuristics are equally important drivers. For 
example, the regret that people associate with potential adverse events after MMR vaccination has 
been shown to be a key predictor of MMR uptake [11]. Other studies have shown that many factors 
that affect behavior are unrelated to facts or awareness, and that traditional modes of health education 
that are more message-driven rather than dialog-promoting, may have only a small impact on  
behavior [12,13]. A recent systematic review of the evidence for effective national immunization 
schedule promotional communications found no evidence that improved knowledge led to increased 
childhood vaccine uptake, or even intention to vaccinate [14].  
To date, much of the literature on vaccination decision-making has identified attitudinal and 
demographic correlates of complete and incomplete vaccine uptake largely in individuals. The published 
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research has mostly been uni-disciplinary—i.e., drawing from a single specialty (like psychology, or 
sociology, or public health). While important, the field needs to draw from a range of rich theoretical 
understandings in other areas of health that can inform more holistic frameworks to understand vaccine 
decisions and their motivations. Multi-disciplinary approaches to understanding vaccination behavior 
could also further extend the evidence base, making the most of the tools and frameworks available 
within the different disciplines. Finally, further development of the field will require the design and 
evaluation of theory, and evidence-informed interventions at an individual, community, and national 
level to address the identified influences of vaccination decisions. 
This paper reports on a two-day workshop with a multidisciplinary group of experts aimed at 
mapping, firstly, the known and potential drivers and barriers to vaccination at the individual and 
societal level, and, secondly, a research framework that allows future research to address them.  
Our ultimate aim was to inform a new research agenda from a rich multidisciplinary evidence base to 
inform vaccination program design and policy making.  
2. Methods 
In December 2010, an international think tank called ―MOTIV‖ (Motors of Trust in Vaccination) 
was convened in London. The think tank deliberately assembled professionals with diverse expertise 
both within, and beyond, vaccinology. The 15 participants were variously expert in medical science, 
vaccinology, epidemiology, pediatrics, immunization policy and programs, immunization behavior, 
global health, psychology, anthropology, sociology, decision science, communication science, advocacy, 
public engagement, and manufacturing. The specific aim was to map the complex web of factors that 
may influence decision-making about vaccines at all levels, including individuals, peer groups, clinicians, 
and policy makers.  
These aims were addressed through a range of interactive sessions. First, a structured brainstorm was 
carried out where members were asked to spontaneously identify factors affecting vaccination-related 
behavior—including vaccine acceptance, hesitancy, and refusal—by consumers, professionals, and 
policy makers. This involved the use of a ―reverse brainstorm‖ technique to help participants look at 
issues around vaccination uptake ―through new eyes‖. Here, participants were asked to consider the 
issue of vaccination from the opposition point of view—and think of ways to make uptake of a vaccine 
program as poor as possible (in this case a fictitious new vaccine with data from clinical trials showing 
acceptable levels of safety and efficacy).  
Following the reverse brainstorm, participants identified factors/determinants of vaccine decision-
making. The ideas were captured in an iterative manner and clustered by MOTIV participants into three 
major domains. Participants were then assigned to three teams that would each explore one of the major 
domains. Each team reviewed the list of factors/determinants in their assigned domain and then ranked 
them based on their expert perceptions according to importance, level of evidence, feasibility/actionability, 
and the need for more research. These key factors/determinants were distilled into research questions 
that could be taken forward for further investigation. Key factors/determinants for which a research 
framework could be developed were finally identified and discussed within the entire MOTIV group.  
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3. Results  
The brainstorming identified poor communication, safety concerns, political issues, anti-vaccination 
activism, and animal rights as the major areas under which a vaccine program might be derailed.  
Regarding determinants of vaccination decision-making, the MOTIV expert group identified  
61 factors that may affect vaccination-related behavior in consumers, professionals and policy makers 
(Appendix 1). These factors were further iteratively organized into ―clusters‖, which were grouped 
under three major domains: cognition and decision-making; groups and social norms; and communications 
and engagement.  
Research questions for further investigation were derived across the three major domains of 
influence on vaccination uptake, as detailed below. Boxes 1 and 2 illustrate two exemplars of such 
research questions.  
Box 1. Which cognitive processes mediate vaccine decision-making and what are their 
relative roles in different contexts? 
A range of cognitions influence vaccination decision-making, including heuristics. These 
are cognitive shortcuts used for making decisions about risk. One well-described heuristic 
in vaccination decisions is omission bias. This bias occurs if poor outcomes arising from an 
―action‖ (e.g., a reaction to a vaccine arising from deliberate acceptance of a vaccine) are 
viewed more unfavorably than poor outcomes arising from an ―inaction‖ (e.g., disease 
contraction arising from ―taking a chance with fate‖), even if those outcomes are 
objectively identical, or omission is in fact more risky. Psychologically, omission bias has 
been linked to the emotion of regret: decision-makers tend to experience more regret for an 
outcome that they perceive as a consequence of their own voluntary ―action‖ than for the 
very same outcome if that is perceived to be a consequence of luck or fate. Within the 
context of immunization, typically immunizing is seen as a conscious ―action‖ whereas not 
immunizing (i.e., ―doing nothing‖) is seen as ―inaction‖. Evidence for omission bias has 
been demonstrated in relation to pertussis [11,12], MMR [13] and H1N1 vaccines [14]. 
Following the identification of drivers and barriers to vaccination and the related decision  
making processes, we sought to outline a viable research framework. Figure 1 presents an overarching 
framework aimed at outlining and systematizing a multidisciplinary research approach that is  
directly linked to evidence-based policy making. The framework is grounded on the types of themes 
that emerged through the expert brainstorming—namely the cognitive, social/interpersonal, and 
communication-related influences on attitudes to immunization and vaccination decision-making.  
A four-step iterative cycle is described. In the first step, descriptive and experimental research offers 
scientific definitions and illustrations of the issues to be tackled (e.g., omission bias in immunization 
decisions). In the second step, the findings are translated into interventions—typically including 
individual decision-makers (e.g., a de-biasing technique to be applied by community nurses or 
physicians offering vaccinations), the wider public, and also healthcare professionals. In the third step, 
these interventions are prospectively evaluated for effectiveness and the findings are fed back into the 
evidence base in the fourth and final step.  
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Box 2. How does engagement with the various publics influence the level of trust in 
vaccines, vaccinations and vaccination-promoting groups or organizations?  
Which public engagement strategies within the areas of vaccination decision-making and 
broader healthcare have achieved their goals, and how and why have they achieved their goals?  
How does/should communication and engagement change according to culture, geographical 
region or broadcast channel? 
Public engagement is an umbrella term for a range of activities that occur at the interface 
between the specialist and non-specialist. Engagement is defined more by its ethos than by 
the vehicles of engagement. A key consideration is power: who is driving an engagement 
process, who owns the conversation, and how far can this process meet different stakeholders‘ 
multiple agendas? The emphasis of engagement is not to get public buy-in for a health 
program or technology; it is something more collaborative than lobbying or campaigning and 
goes beyond health promotion. Engagement aims to catalyze a two-way interaction, and 
well-executed public engagement will ultimately enable more critically aware, insightful 
decisions for all parties. This may be breaking new and difficult ground for many professionals 
and scientists and is therefore an important area for future research. 
Figure 1. A dynamic multidisciplinary research framework to drive evidence-based policy 
making in vaccination. 
 
I-Problem definition 
Mapping, segmenting, weighting of 
known vaccination drivers, barriers & 
influences on decision-making 
Research & development: Psychological, 
social & cultural influences on decision-
making 
II-Research application 
Design and implementation of 
decision-making tools, policy 
approaches, public engagement 
programs & medical education 
IV-Review & refinement 
Increased understanding and revised 
research and development programs 
III- Assessment of impact 
Measurement of impact of 
interventions on attitudes and 
behaviours of the public & healthcare 
professionals 
Tracking of public reactions & attitudes 
to immunization; public health 
epidemiology 
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Importantly, the framework rests on robust multidisciplinary research and development process—
which includes key social and behavioral sciences. It also identifies the need for real-life longitudinal 
tracking not only of coverage and disease outbreaks via epidemiological methods, but also of behavioral 
and social reactions to immunization. The latter are aimed as explanations for and predictors of the former.  
The basic premise of the framework is a dynamic approach to the generation and evaluation of new 
evidence to drive policy-making and program design. Vaccine decision-making is recognized here as a 
dynamic field of enquiry that can be rapidly affected by new vaccine developments, novel social 
movements (e.g., newly emerging social networks) and the increasing quest for evidence-based policy. 
The iterative link described here between multidisciplinary science and real-life coverage/attitudes to 
vaccines allows this framework to offer insights into policy making.  
4. Discussion 
The MOTIV workshop brought together a multidisciplinary group of experts and aimed at mapping 
drivers and barriers to vaccination to inform future research priorities. The ultimate aim of the 
workshop was to contribute to a contemporary research agenda, which will in turn inform vaccination 
policy-making and program design (in the manner outlined in Figure 1). It is clear from the  
factors identified that public engagement around vaccines needs to be broad and multifactorial,  
with engagement at multiple levels. These include policy-making (e.g., deliberative democracy), 
program design (including delivery) and the development of risk communication strategies.  
Methodological improvements are required for better understanding of vaccine decision-making 
across populations and contexts and over time. Self-reported vaccine uptake and cross-sectional studies 
(where we assume causation between a certain attitude and behavior from measurements made only at 
one time point) limit the robustness of research into vaccination decision-making. In this context, 
attention to improving research design and data quality is essential, to provide a clear understanding  
of the relative contribution of factors such as trust, risk perception, online networks, peer networks,  
and misinformation.  
Theoretically sound research frameworks and validated methods are also important. Use of recent, 
robust evidence-based attitude measurement instruments to evaluate the predictors of MMR uptake 
clearly shows that differences exist in the way vaccine-acceptors and vaccine-decliners think about 
several key factors regarding vaccination and disease control [15].  
The MOTIV approach has some limitations. The faculty consisted of experts across diverse fields 
but did not exhaust the range of potentially relevant areas of expertise. Moreover, during the group 
sessions it was agreed that the domain ―Communication‖ is too broad an area and more specific 
research topics need to be defined within the broader realm of communication. Additionally there was 
a significant degree of crossover between the domains—for example ―Trust‖ overlaps with ―Public 
engagement‖. The question of ―What influences policy decision-making?‖ was identified as missing 
and was subsequently added to the decision-making category. Further, no formal consensus building 
methods were applied, as the idea-generation techniques used throughout the workshop were  
solely qualitative. 
These limitations notwithstanding, we take the view that the questions outlined, and the proposed 
framework, are timely. Recent global events have demonstrated a desire for strategic attention to 
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vaccine decision-making. The need to strengthen public support for vaccination efforts is one of the 
four components that comprise the Global Vaccine Action Plan, endorsed by the World Health 
Assembly (2012), and catalyzed by the Decade of Vaccines collaboration [13]. Additionally, WHO 
Strategic Group of Experts (SAGE) on immunization created a working group to specifically address 
vaccination hesitancy in 2012.  
Just as vaccine development and testing is informed by science and research, so must our understanding 
of vaccine decision-making by publics, professionals, and policy makers be informed by robust 
scientific methods. This understanding will more credibly inform appropriate interventions to support 
decision-making. This framework provides the groundwork for a more explicitly articulated research 
agenda on vaccine decision-making. It suggests cross-disciplinary investigations (e.g., applying social 
networking theories to understanding community influence) and provides a starting point for 
researchers to identify areas well understood and those needing further enquiry.  
An approach to researching vaccine decision-making and to translating the research findings into 
usable building blocks for policy making has been described, involving a range of multidisciplinary 
factors that cannot be addressed simply with existing health metrics or by one discipline alone.  
5. Conclusions  
The aim of the MOTIV think tank was to map what we do and do not know about the drivers  
of vaccination decision-making, and to look beyond the traditional ―one-way‖ approach to health 
information. In-depth understanding of complex decision-making processes—through appropriate 
collaborative research across multiple disciplines—is key to better understanding the drivers and 
barriers of trust in vaccination, and defining how best to engage publics. This provides a first step 
towards building a dynamic multidisciplinary research network, in both developed and developing 
countries, that can synthesize research findings within a coordinated research program, develop 
interventions, and eventually facilitate increasingly evidence-based vaccination policy.  
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Appendix  
Appendix 1. Factors (Drivers and Barriers) Affecting Vaccination Uptake and Sample  
Research Questions. 
Domain Cluster Potentially influencing factors Sample research questions 
Cognition and  
decision-making 
Trust 
1. Trust in national institutions 
2. Trust in healthcare workers 
3. Trust in authorities/experts 
4. Trust in research 
5. Trust in policy 
makers/accountability 
6. Trust in media 
7. Trust in official information 
8. Trust in vaccine industry 
9. Trust in vaccines 
10. Interpersonal trust 
11. Industry-policy maker-researcher 
trust 
12. Transparency 
13. Competency 
-How should trust be measured?  
What are the drivers of trust (intellectual, 
personalities, environmental—external 
physical drivers, etc.)?—Who do 
different groups trust? Who are real 
influencers?  
-Do different publics trust the media 
differently?  
-What is the trust spectrum for vaccines?  
-Who influences different population 
segments (e.g., mapping trust networks)?  
-What determines trust in a) health 
officials and experts; b) healthcare 
workers; and c) policy makers?  
-How can public confidence in 
vaccination be engendered, protected and 
measured?  
Risk and 
perception 
14. Heuristics (e.g., confirmatory 
bias, regret bias, omission bias) 
15. Post-hoc rationalisation 
16. Risk-benefit assessments  
17. Scientific/medical literacy  
18. Physical sensations 
19. Perceptions about the faith and 
fear of injecting substances  
20. Perceptions regarding vaccine 
adverse events, including their 
likelihood and severity  
21. Invisible disease (low perception 
of risk) 
-Which heuristics are most prevalent or 
widely used when it comes to vaccine 
decision-making?  
-How do you change an individual‘s 
norm or reference point? 
-How multiple heuristics interact in 
vaccine decision-making? 
Why are some issues very  
vaccine-specific whereas others concern 
several vaccines? 
-Do actions or thoughts/feelings  
come first? 
What is the impact of fear? 
-Can we create a segmentation of 
different decision-making styles 
How do people interpret messages 
(mental shortcuts, biases, heuristics) and 
overestimate risks? 
-Do healthcare workers decide differently 
for patients vs. themselves? If so, what 
influences this?  
-Do healthcare workers‘ perceptions 
mirror those seen in public? Are 
healthcare workers‘ perceptions different 
from those of the public?  
-Why do healthcare workers not accept 
vaccines themselves—even if they 
recommend them to their patients?  
Can we measure ―what‖ and ―how‖ 
people understand and remember 
(information, experiences)? 
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Appendix 1. Cont. 
Domain Cluster Potentially influencing factors Sample research questions 
Cognition and  
decision-making 
Decision context 
22. Competing priorities;  
Practical barriers to access 
23. Weighting of the factors may 
change depending on the 
context  
24. Multi-factorial equation 
involving the individual and 
groups (institution, culture, 
religion, social network) 
25. Experience of adverse events 
and how they are managed  
26. Safety research on vaccines (at 
an individual level 
27. Mandatory vaccination transfers 
decision-making away from 
people and leads to opposition 
and controversies 
28. Level of education/literacy/  
scientific and health literacy 
-For which segments is having a 
vaccine a decision?  
-What makes vaccines a lower priority?  
-Why are some issues very vaccine-
specific whereas others concern several 
vaccines? 
-Which public and individual contexts 
influence vaccine  
decision-making? 
-What is the relationship between 
decision-making and notions of  
climate change?  
How can healthcare systems adapt to 
different public attitudes (policy 
through to implementation)? 
Why do some controversies remain 
local or specific to one particular 
vaccine? 
Macro perspectives are needed to link 
behavior to the broader context (e.g., 
government) within a theoretical 
framework 
To what extent do vaccine-critical 
groups influence decision-making? 
Poor literacy leads to low uptake but 
good literacy also leads to low uptake. 
Can we solve the puzzle? 
Who are the policy influencers? 
Groups and  
social norms 
Groups/grouping 
29. Social networks 
30. Religious groups 
31. Groups by education-level  
32. Alternative medicine groups 
33. Political groups 
34. Anti-vaccination groups 
35. Family groups/structures 
36. Patient groups 
37. Consumer groups 
38. Professional groups 
39. Peer pressure 
40. Heterogeneous groups 
41. Demographic (socioeconomic) 
groups 
42. Influence of alternative 
healthcare givers such as  
Chinese medicine 
What is the role of parental questioning 
about health and education and the shift 
towards ‗intensive‘ parenting? 
Role of peer pressure? 
How do memes (a unit of cultural 
information transferable from one mind 
to another) travel between groups in a 
constantly and globally connected 
society? 
What is the role of culture and religion 
on decision-making? 
How do a few anti-vaccine individuals 
influence the ‗swing voters‘/vaccine  
hesitants? 
Understand the heterogeneity of 
groups/publics 
Role of social pressure and altruism in 
decision-making. What are the benefits 
to society? 
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Appendix 1. Cont. 
Domain Cluster Potentially influencing factors Sample research questions 
Groups and  
social norms 
Groups/grouping 
 Define the network of influencers and 
the context. What is the best way to 
communicate with this network? 
Can we develop a new model to measure 
and/or assess the level  
of influence? 
What are the factors that make a family 
vaccination strategy (e.g., ―cocoon‖ 
strategy in pertussis)  
―to protect your family members‖ 
successful or not? 
Can we learn lessons from military 
strategy about engaging with publics, 
especially with respect to parallel access 
and trust building and ―hearts and 
minds‖ campaigns?  
Is there a way to better understand 
and/or to classify vaccine-critical 
groups? Is there a real/organised  
anti-vaccine lobby? 
Social norms 
43. Social and cultural norms 
44. Vaccination as a routine/norm 
-Which social norms influence 
vaccination decisions?  
-How can acceptance of safe, effective 
vaccines be sustained as a social norm? 
-How do different types of protective 
norms influence decision-making? 
Communications 
and engagement 
Sender 
45. Healthcare workers 
communication skills 
46. Physicians poor  
vaccine education 
47. Media 
48. The authority of the messenger 
impacts the credibility of the 
source of the information 
49. Tone in communication 
50. Ensuring that people feel 
―listened to‖ 
51. Level of how informed and 
educated (content of training) 
the media and journalist are 
52. Health care workers level of 
confidence in providing 
information to their patients 
53. Healthcare worker temperament 
How do physicians communicate with 
patients? How do patients communicate 
with physicians? What are the outcomes 
of these interactions? 
What is the impact of fear? 
How should messages be framed or 
constructed? How does the use of 
exemplars and narratives apply  
to vaccination? 
How do ideas travel and how do we 
communicate with each other in the 
―connected generation‖? What does 
―constantly connected‖ mean? 
Is Institute of Medicine report on 
consumer-provider relationship 
regarding vaccines globally relevant? 
What are the sources that journalists use 
for information? How credible are these 
sources? 
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